** U.S.-listed shares of Akanda Corp AKAN.O jump 38% to
$1.08 premarket on pact to supply pharmaceutical grade cannabis
to Tetra Bio-Pharma urn:newsml:reuters.com:*:nPnc93vTWa
** Under deal, UK-based medical cannabis company AKAN to be
contract development and manufacturing organization for Tetra's
clinical drug and commercial supply programs, in addition to
being an EU GMP cannabis manufacturer
** Deal marks AKAN's entry into cannabinoid drug development
** AKAN shares down 80% from its IPO price of $4, up to last
close; stock listed in March urn:newsml:reuters.com:*:nASM0003IO
(Reporting by Leroy Leo in Bengaluru)
((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))